Avitar to acquire Genua:
This article was originally published in Clinica
Executive Summary
Avitar is expanding its presence in the rapid diagnostic test market with the planned stock purchase of Genua, a privately-held diagnostics company. Genua developed its Rapid Saliva Kits for HIV and hepatitis which include a custom-designed form of Avitar's Accu-sorb saliva collection devices. Genua recently revealed positive results of correlation studies for these tests, conducted at the Nassau County Medical Center, East Meadow, New York. Furthermore, Genua owns distribution rights to drugs-of-abuse and pregnancy tests. Avitar is a manufacturer of a range of healthcare products including Hydrasorbd, a line of polyurethane dressings.